Business news

    US markets rallied; Moderna rose on advisory committee outcome; Walgreens expands into health-care via VillageMD

    Article Image
    Highlights
    • The Nasdaq rose 1.7% to finish Thursday?s session at 14,823 points.
    • Moderna rose 3% on US FDA advisory committee booster approval.
    • Walgreens surged 7% after announcing expansion into health-care.

    The US markets closed higher on Thursday following the release of better-than-expected earnings results from a number of companies, and the fall in Treasury yields for a third straight decline.

    The Dow Jones rose 1.56% to finish the trading day up 535 points to close at 34,913 points.

    The tech heavy NASDAQ rose 1.7% to finish the trading day up 252 points to close at 14,823 points with Google and Apple gaining 2.55% and 2.02% respectively.

    One bitcoin is worth US$57,466 going into the Asian trading day.

    The Australian dollar is firm against the major currencies and is buying 74.18 US cents.

    Moderna shares rose 3.23% yesterday after the US FDA?s vaccine and related biological products advisory committee voted unanimously in favour of recommending the US FDA authorise Moderna?s COVID-19 vaccine booster shot for adults over 65 years old and anyone under 65-years who is vulnerable with underlying medical conditions.

    Shares in America?s second-largest pharmacy store chain Walgreens surged 7.43% on Thursday after the company announced plans to expand into the health-care division. Walgreens is planning to open hundreds of doctors offices, offer in-store nurse consults and join the pharmacies onto the chains through the acquisition of primary care company VillageMD.

    And McDonald's will begin selling plant-based Beyond Meat burgers in select US stores from next month to trial the patties as part of its deal with Beyond Meat.

    Disclaimer

    Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relates to your unique circumstances. Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of, or reliance on the information provided directly or indirectly by use of this platform.

    Publisher
    Grafa